Fig. 3
From: Mitochondrial pyruvate carrier: a potential target for diabetic nephropathy
Quantitative analysis of MPC1 and MPC2 expressions. MPC1 expression in PGN, PGN-DM and DN groups (a). MPC1 expression in different types of pathology in the PGN group (b) and PGN-DM group (c). MPC1 expression among different pathological stages of DN (d). MPC2 expression in PGN, PGN-DM and DN groups (e). MPC2 expression in different types of pathology in the PGN group (f) and PGN-DM group (g). MPC2 expression among different pathological stages of DN (h)